BioLineRx (BLRX) Amortization of Deferred Charges (2019 - 2025)
BioLineRx's (BLRX) quarterly Amortization of Deferred Charges came in at $702000.0 in Q1 2025, up 2500.0% quarter-over-quarter from $27000.0 in Q4 2024.
BioLineRx (BLRX) Amortization of Deferred Charges (2019 - 2025) Analysis & Trends
BioLineRx's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $702000.0 for Q1 2025.
- On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $702000.0 in Q1 2025; TTM through Dec 2025 was $702000.0, a 202.59% increase from a year earlier, with the FY2025 full-year figure at $702000.0, up 4.93% from the prior year.
- Amortization of Deferred Charges improved to $702000.0 in Q1 2025 per BLRX's latest filing, from $27000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $702000.0 in Q1 2025 and bottomed at $27000.0 in Q4 2024.
- The 5-year median for Amortization of Deferred Charges is $139000.0 (2022), against an average of $215400.0.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 702,000.00 |
| Mar 31, 2025 | 702,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2023 | 66,000.00 |
| Sep 30, 2023 | 66,000.00 |
| Dec 31, 2022 | 139,000.00 |
| Dec 31, 2022 | 139,000.00 |
| Sep 30, 2021 | 143,000.00 |
| Sep 30, 2021 | 143,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Mar 31, 2019 | 417,000.00 |
| Mar 31, 2019 | 417,000.00 |